Dr. Stahl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Avenue
Memorial Sloan Kettering Cancer Center
New York, NY 10065Phone+1 646-497-9154- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2018
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2014 - 2017
- Hannover Medical SchoolClass of 2012
Certifications & Licensure
- MA State Medical License 2021 - 2024
- CT State Medical License 2017 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.Shimony, S., Bewersdorf, J., Shallis, R., Liu, Y., Schaefer, E., Zeidan, A., Goldberg, A., Stein, E., Marcucci, G., Lindsley, R., Chen, E., Ramos Perez, J., Stein, A.,...> ;Leukemia. 2024 Feb 20
- Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.Lane, A., Garcia, J., Raulston, E., Garzon, J., Galinsky, I., Baxter, E., Leonard, R., DeAngelo, D., Luskin, M., Reilly, C., Stahl, M., Stone, R., Vedula, R., Wadleigh...> ;Blood Advances. 2024 Feb 13
- Is there a path forward for immunotherapy in patients with myelodysplastic syndromes?DeZern, A., Stahl, M.> ;The Lancet. Haematology. 2024 Jan 1
- Join now to see all
Lectures
- Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients with Myelodysplastic Syndromes (MDS): Results of a L...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- What Is the Best Method for Cytoreduction in Patients with Acute Myeloid Leukemia and Hyperleukocytosis?February 1st, 2021
- Alternative Option to Intensive Chemotherapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)December 6th, 2016
Hospital Affiliations
- Memorial Sloan-Kettering Cancer CenterNew York, New York
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: